TSquared Lab has announced the launch of TSquared Health, a new company focused on longevity, following its acquisition of Noviu Health. This initiative integrates advanced biomarker testing, wearable-derived insights, and AI-supported clinical guidance to offer a comprehensive approach to preventive care and healthspan optimisation. The acquisition expands TSquared Health’s clinical operations to two locations in Singapore, including a new flagship clinic in the Central Business District.
The medical strategy for TSquared Health will be overseen by Dr Hisham Badaruddin, a physician with extensive experience in metabolic and hormonal health. He emphasises the importance of data-informed personalised medicine, which aligns with TSquared Health’s commitment to rigorous, data-driven longevity care. “By combining biomarker testing, structured interpretation, and real-world intervention under one ecosystem, we can meaningfully shift the trajectory of our clients’ long-term health,” said Dr Badaruddin.
TSquared Health introduces the TSquared Healthspan Intelligence Engine, an AI system that transforms biomarker, wearable, and lifestyle data into a personalised healthspan score. This system provides clients with clear, actionable steps for health improvement, reviewed by experienced physicians to ensure medical soundness.
The launch addresses the growing demand for proactive healthcare in the region, driven by rising metabolic and lifestyle-related conditions. TSquared Health aims to democratise access to high-quality preventive testing through its Signature and Elite membership tiers, making longevity care more accessible and actionable for a broader audience.
